Insights from
UBC's Expert Voices

From triage to causality assessment, AI is changing how case processing teams work. We break down five areas where automation is making an impact, and the human expertise that still has to anchor every decision.

Psychedelic-assisted therapies are emerging as a promising frontier for treatment-resistant mental health conditions. As the regulatory landscape evolves, robust risk management frameworks will be critical to bringing these therapies safely to patients. UBC explores the current landscape and what approval pathways may mean for sponsors.

Automation and AI are often used interchangeably in PV, but they're built for different jobs. This piece breaks down where each one delivers value, and how to choose the right fit without adding unnecessary complexity.

AI is everywhere in PV conversations, but far less mature in practice. Here's what stood out from Why Summit: Future of PV: validation bottlenecks, signal inflation, and why the real challenge isn't technology.

AI, standardization, and a shifting FDA landscape — here's what the 2026 RIC Annual Meeting revealed about the future of REMS.

Canada's consent-driven data silos and the U.S.'s regulatory patchwork aren't just administrative hurdles — they're determinants of bias in real-world evidence.

Implementing Regulation (EU) 2025/1466 is in full effect — and it's the biggest change to EU pharmacovigilance rules in over a decade. Here's what your compliance team needs to act on right now.

Two phrases defined this year's Access USA conference: "calm the chaos" and "can't eliminate the human touch." As AI reshapes patient support programs, the question isn't whether to adopt it, but how to deploy it without losing what patients value most.

Women's depression is often framed as a hormonal imbalance of the body. Men's? A failure of will. These aren't just outdated ideas — they're active barriers to diagnosis, treatment, and survival. As treatment-resistant depression challenges conventional medicine, psychedelic-assisted therapy is emerging not only as a clinical option, but as a way to dismantle the very stigmas that keep people from seeking help in the first place.